Kerley B Lines on Chest X-Ray: Heart Failure Signs Explained for Medical Students

On chest x-ray, septal interstitial pattern collapses into Kerley lines: Kerley B lines are short 1-2 cm horizontal lines near lung periphery at bases and costophrenic angles; Kerley A lines are 2-6 cm radiating lines from hilum in middle/upper lung zones. Approach to interstitial opacities follows: Kerley lines suggest pulmonary edema unless lymphangitic carcinomatosis is suspected; coarse patterns suggest infectious bronchiolitis or chronic causes (fibrosis, sarcoidosis, fibrotic HP, pneumoconiosis); fine patterns on poor-quality images are indeterminate due to artifact. If confident in true finding, determine reticular vs nodular pattern. Reticular patterns suggest interstitial fibrosis, sarcoidosis, or fibrotic HP; nodular patterns suggest infectious bronchiolitis, sarcoidosis, or pneumoconiosis.

Diffuse consolidation affects both lungs bilaterally and requires careful evaluation of cardiac silhouette. An increased cardiothoracic index suggests cardiac origin (e.g., congestive heart failure). Kerley B lines (linear opacities at lung bases) indicate interstitial edema. Cardiac enlargement and pleural effusions support cardiogenic etiology. Non-cardiogenic causes include vasculitis (Lupus, Wegener's granulomatosis), hypersensitivity pneumonitis, lymphoma, and Pneumocystis pneumonia. Differentiating between cardiogenic and non-cardiogenic causes is crucial for appropriate management.

Interstitial edema patterns on chest X-ray include Kerley B lines (horizontal lines at lung bases), Kerley A lines (vertical lines at lung bases), Kerley C lines (reticular pattern throughout lung fields), and ground glass pattern (diffuse haziness). Upper zone interstitial edema suggests interstitial pneumonia, connective tissue disease, drug-induced lung disease, or sarcoidosis. Lower zone interstitial edema suggests interstitial fibrosis, idiopathic pulmonary fibrosis, asbestosis, or hypersensitivity pneumonitis. The distribution helps narrow the differential diagnosis and guide further investigation.

This extensive section covers interstitial lung disease classification and diagnostic approach. Interstitial opacities are classified by radiographic appearance: reticular patterns (excessive linear markings creating lace-like appearance), nodular patterns (numerous small dots/nodules, <1 cm; miliary pattern if all <2 mm), and reticular-nodular patterns (combination of both). The differential diagnosis is large and challenging: reticular patterns include idiopathic pulmonary fibrosis, connective tissue disease, atypical pneumonia, idiopathic interstitial pneumonias, asbestosis, chronic aspiration, drug toxicity, sarcoidosis, hypersensitivity pneumonitis, Langerhans cell histiocytosis, and lymphangitic carcinomatosis. Nodular patterns include small nodules (<2 cm): miliary tuberculosis, fungal infections, silicosis, coal workers pneumoconiosis, sarcoidosis; medium/large nodules (>2 cm): metastatic cancer, subacute hypersensitivity pneumonitis, lymphoma, granulomatosis with polyangiitis, rheumatoid nodules. Sarcoidosis appears across all lists due to its diverse manifestations. Comparison of alveolar vs interstitial: alveolar respect lobar boundaries, have hazy margins, may contain air bronchograms, change rapidly, and use subjective descriptions; interstitial do not respect boundaries, have sharp margins, lack air bronchograms, evolve slowly, and use semi-objective terminology.

Kerley B lines are horizontal linear structures visible on chest radiographs in the peripheral lung regions, representing thickened interlobular septa that are normally invisible; they primarily indicate interstitial edema from left-sided heart failure or lymphangitic carcinomatosis, with the lines appearing as ladder-like patterns near the pleural surface and costophrenic angles.

Acute heart failure management requires phenotyping: vascular congestion (left-sided, orthopnea, B-lines) responds to vasodilators, while tissue congestion (right-sided, edema, elevated CA-125) responds to higher diuretic doses. Diuretic response assessment: initial furosemide 20-40 mg daily. If no response, measure urinary sodium at 2 hours post-furosemide. Adequate response: urinary sodium 50-70 mmol/L and urine output 100-150 mL/hour. If inadequate, double the dose. If urinary sodium <50 mmol/L despite escalation, add acetazolamide (if furosemide <80 mg/day) or hydrochlorothiazide (if furosemide >80 mg/day). Congestion-related renal dysfunction is common; if patient remains congested despite adequate urinary sodium, increase diuretic dose without fear of worsening renal function.

This section covers the complete management of acute decompensated heart failure. Clinical presentation includes dyspnea, orthopnea, JVD, peripheral edema, and pulmonary crackles. Diagnostic approach compares BNP (limited by elevation in renal failure, sepsis, burns, and AFib), chest X-ray (20% false negatives), and lung ultrasound (88% sensitivity vs 73% for X-ray using B-lines). Treatment algorithm emphasizes nitrates (preload reduction, caution in aortic stenosis, RV infarction, tamponade; always check for sildenafil), IV loop diuretics (furosemide, bolus vs continuous equivalent), and NIPPV (CPAP/BiPAP early, avoid in vomiting/AMS). Morphine is contraindicated due to increased ICU admission and mortality. For cardiogenic shock: NIPPV + norepinephrine (MAP >60) + dobutamine. Summary: nitrates, NIPPV, diuretics, avoid morphine.

Acute decompensated heart failure is classified using the volume-temperature paradigm into four categories: warm-dry (compensated, asymptomatic), warm-wet (most common, volume overload with normal cardiac output), cold-wet (next most common, low cardiac output with volume overload), and cold-dry (least common, low cardiac output without volume overload). Treatment differs by category: warm-dry patients receive gradual neuro-hormonal blockade titration; warm-wet patients need loop diuretics and vasodilators; cold-dry patients require cautious fluid boluses and inotropes; cold-wet patients need inotropes and diuretics with careful blood pressure management. Key treatment principles include prompt IV diuretic administration (furosemide 20-40mg IV initially), avoiding excessive oxygen supplementation, and using BNP levels for prognosis rather than diagnosis.

Acute decompensated heart failure presents with orthopnea (difficulty lying flat), exertional dyspnea, bilateral edema, elevated JVP, and pulmonary crackles. Physical examination reveals volume overload signs including hypertension, peripheral edema, and stasis dermatitis. Laboratory evaluation includes BNP/NT-proBNP, lactate, and anemia workup. Aggressive diuretic therapy (IV furosemide 40-80 mg) is essential for unstable patients. Delayed diuretic response indicates need for escalation including catheterization and inotropic support.

Acute decompensated heart failure occurs when the body can no longer compensate for reduced cardiac function. Initial compensation involves increased heart rate and vascular resistance, but these mechanisms eventually worsen heart failure by forcing the heart to work harder. Symptoms include jugular venous distension, pulmonary crackles, and peripheral edema from fluid backing up in the heart. Clinical reasoning distinguishes between 'first' questions (requiring sequential assessment before intervention) and 'best' questions (identifying the highest priority action regardless of timing). For example, elevating the head of bed before administering furosemide makes clinical sense, whereas giving diuretics while flat is ineffective.

Point-of-care ultrasound (POCUS) systematically evaluates respiratory causes of acute dyspnea through three key questions: (1) Does pneumothorax exist? Look for absent lung sliding and identify lung points at the anti-dependent chest wall location; (2) Is there pleural collection? Assess diaphragmatic views to detect fluid accumulation, which ultrasound detects more accurately than chest X-ray; (3) Are there inflammatory/infectious findings? Identify irregular pleural thickening, skip-sign B-lines (focal/patterned distribution), or massive consolidations with air bronchograms to distinguish from pulmonary edema's regular, symmetric B-line pattern. Absence of these findings combined with clinical history suggests obstructive pulmonary disease (COPD/asthma) exacerbation.

Thoracic ultrasound, once considered useless due to lung artifacts, is now widely used in critical care. Lung sliding is a glistening pleural movement visible on ultrasound that excludes pneumothorax with 100% certainty when present. B lines are vertically oriented hyperechoic artifacts indicating interstitial lung thickening, characteristic of pulmonary edema. The number of B lines is semi-quantitative, increasing with lung water content. These findings allow rapid differentiation between normally aerated lungs (A-line pattern) and pulmonary edema (B-line pattern) in acutely dyspneic patients.

Point-of-care ultrasound (POCUS) provides a rapid, bedside algorithmic approach to diagnose acute dyspnea by systematically evaluating lung artifacts (sliding for pneumothorax, A-lines and B-lines for pulmonary edema, consolidation and pleural effusions), cardiac function (parasternal views for ejection fraction and pericardial effusion), inferior vena cava (IVC) for fluid status, and deep vein thrombosis (DVT) for pulmonary embolism, offering advantages over chest X-ray and CT including flexibility, immediate availability, and zero travel time for critically ill patients.

Chest X-ray is fundamental in dyspnea evaluation: cardiomegaly and pleural effusion suggest heart failure, while a normal chest X-ray has a negative likelihood ratio of 0.11 for heart failure. False negatives for pneumonia are common, especially in early presentations. Point-of-care ultrasound (POCUS) significantly improves diagnostic accuracy, increasing correct diagnoses from 59% to 91% (32% absolute risk reduction). POCUS identifies pneumothorax (lung point, barcode sign), pleural effusion, pneumonia, and heart failure. The technique has a rapid learning curve and is particularly useful for emergency physicians. POCUS combined with standard tools has sensitivity of 79-95% and specificity of 63-100%.

B-lines on lung ultrasound are reverberation artifacts that indicate interstitial pulmonary edema; they must originate at the pleural line, widen as they extend downward, and erase A-lines to be considered pathological, requiring 2-3 B-lines in adjacent rib spaces for diagnosis, as opposed to false Z-lines which do not originate at the pleural line and do not widen.